Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2025 –2032 | |
|
|
USD 700.32 Billion |
| USD 1,116.20 Billion | |
| % | |
Global Uveitis Market Segmentation, By Type (Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis, Others), Diagnosis (Visual Acuity Test, Funduscopic Exam, Ocular Pressure, Slit Lamp Exam, Others), Treatment (Anti-inflammatory, Antibiotics, Immunosuppressive, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2032
The global uveitis market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The growth of global uveitis market enhanced by the growing cases of glaucoma and rise in research and development activities conducted by many pharmaceuticals’ companies. COVID-19 also had a major impact on the market growth.
Global uveitis market size was valued at USD 700.32 billion in 2024 and is projected to reach USD 1116.20 billion by 2032, with a CAGR of 6.00% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Uveitis Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Aerie Pharmaceuticals, Inc. (U.S.), Allergan (Ireland), Bausch Health (U.S.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Fera Pharmaceuticals (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), EyePoint Pharmaceuticals,Inc (U.S.) Amorphex Therapeutics Holdings, Inc (U.S.), Kubota Vision Inc (U.S.)., Alcon (Switzerland), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (U.S.), Carl Zeiss Meditec AG (Germany), Nidek Co Ltd (India), Accutome,Inc (U.S.), AqueSys (U.S.), Iridex Corporation (U.S.)
|
|
Market Opportunities
|
|
Uveitis Market Definition
Uveitis is the group of inflammatory disease that damages the eye tissue and produces eye swelling mainly uvea part. Uvea supplies blood to the retina, retains is the light sensitive part of the eye that focus the image on brain, due to this disease impaired vision or completely vision loss occurs. Symptoms of uveitis include eye redness & pain, light sensitivity, blurred vison, decreased vision. Patients with AIDS, psoriasis, tuberculosis, ulcerative colitis, sarcoidosis, rheumatoid arthritis are at higher risk to get eye disorders.
Uveitis Market Dynamics
Drivers
The geriatric population is expected to increase the patient population globally, which boots the global angiomyolipoma market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050 from 617 million in 2015. This boost the market growth.
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
As per The College of Optometrists, the prevalence of anterior uveitis is 12 per 100,000 people in a year. According to the International Agency for the Prevention of Blindness, it is estimated that around 80 million people will suffer from glaucoma in 2020, a huge increase from 20 million recorded in 2010. In addition to this, over 8 million people were bilaterally blind due to glaucoma, which is expected to increase to over 14 million by 2022.
The rise in the number of open angle glaucoma therapeutics delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global uveitis market over a forecast period.
The huge expenditure associated with uveitis medications surely hamper the market growth.
This global uveitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global uveitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The global uveitis market is segmented on the basis of type, diagnosis, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Diagnosis
Treatment
End User
Distribution Channel
The global uveitis market is analyzed and market size insights and trends are provided by type, diagnosis, treatment, distribution channel and end-user as referenced above.
The major countries covered in the global uveitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe has been witnessing a positive growth for global uveitis market throughout the forecasted period due to the presence of key manufacture of the product, high research and development and healthcare expenditure and skilled professionals.
North America dominates the market due to increased government awareness programs and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The global uveitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global uveitis market
Uveitis Market Leaders Operating in the Market Are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.